TipRanks
Advertisement
Advertisement
Iovance Biotherapeutics price target raised to $7 from $4 at UBS
PremiumThe FlyIovance Biotherapeutics price target raised to $7 from $4 at UBS
1M ago
Iovance Biotherapeutics price target raised to $11 from $10 at Mizuho
Premium
The Fly
Iovance Biotherapeutics price target raised to $11 from $10 at Mizuho
1M ago
Iovance Biotherapeutics put volume heavy and directionally bearish
Premium
The Fly
Iovance Biotherapeutics put volume heavy and directionally bearish
1M ago
Iovance Biotherapeutics Highlights Strong Q2 Growth and Outlook
PremiumCompany AnnouncementsIovance Biotherapeutics Highlights Strong Q2 Growth and Outlook
1M ago
Iovance: Strong AMTAGVI Execution and Global Expansion Support Buy Rating with Unchanged $9 Price Target
Premium
Ratings
Iovance: Strong AMTAGVI Execution and Global Expansion Support Buy Rating with Unchanged $9 Price Target
1M ago
Iovance Expands Solid Tumor Pipeline With New IOV-5001 TIL Trial
Premium
Company Announcements
Iovance Expands Solid Tumor Pipeline With New IOV-5001 TIL Trial
1M ago
Iovance updates outlook, highlighting Amtagvi growth and pipeline
PremiumCompany AnnouncementsIovance updates outlook, highlighting Amtagvi growth and pipeline
3M ago
Iovance Biotherapeutics files automatic mixed securities shelf
Premium
The Fly
Iovance Biotherapeutics files automatic mixed securities shelf
3M ago
Iovance Shareholders Approve Expanded Capital Flexibility and Governance
Premium
Company Announcements
Iovance Shareholders Approve Expanded Capital Flexibility and Governance
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100